Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Tvardi Therapeutics (NASDAQ:TVRD) through any online brokerage.
Other companies in Tvardi Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Tvardi Therapeutics has a consensus price target of $11.86.
The stock price for Tvardi Therapeutics (NASDAQ: TVRD) is $1.31 last updated September 28, 2026 at 4:53 PM EDT.
There are no upcoming dividends for Tvardi Therapeutics.
Tvardi Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Tvardi Therapeutics.
Tvardi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.